Novartis snaps up Tourmaline Bio for $1.4 billion - Betaville.co.uk
Novartis snaps up Tourmaline Bio for $1.4 billion
Some investors were a little disappointed to see news this morning about Novartis's $1.4 billion takeover of US-listed biopharmaceutical company Tourmaline Bio.
You need to register and sign in to read this content.
